Earliest Hepatitis B Infection Detection Demonstrated on
21 Commercial Seroconversion Panels*
GS HBsAg EIA 3.0 Reactivity on Comercial HBsAg Seroconversion Panels Versus Competitors (Earliest Detection Indicated in Bold Type) |
Panel ID# | GS HBsAg EIA 3.0 | HBsAg EIA Competitor #1 (overnight) | HBsAg EIA Competitor #2 |
Static | Shaker |
902 | 7 | 7 | 9 | 9 |
903 | 3 | 2 | 5 | 5 |
904 | 2 | 1 | 3 | 3 |
905 | 1 | 1 | 1 | 1 |
906 | 2 | 2 | 2 | 3 |
907 | 6 | 5 | 6 | 6 |
908 | 6 | 4 | 7 | 7 |
909 | 4 | 3 | 4 | 5 |
910 | 3 | 3 | 3 | 4 |
911 | 20 | 20 | 21 | 22 |
912 | 7 | 6 | 8 | 8 |
914 | 2 | 2 | 5 | 5 |
915 | 1 | 1 | 9 | 11 |
917 | 2 | 2 | 3 | 3 |
918 | 2 | 2 | 3 | 3 |
919 | 5 | 4 | 6 | 7 |
920 | 3 | 3 | 3 | 3 |
924 | 3 | 2 | 3 | 4 |
931 | 5 | 3 | NT | 7 |
932 | 10 | 8 | NT | 10 |
40565L | 2 | 1 | 3 | NT |
* The sensitivity of GS HBsAg EIA 3.0, procedures A and B, was assessed using 20 seroconversion panels purchased from Boston Biomedica, Inc. (West Bridgewater, MA), and 1 panel from Serologicals, Inc. (Clarkston, GA). The number of the bleed at which HBsAg was detected (S/C ≥ 1.0) by the GS HBsAg EIA 3.0, procedures A and B, is compared to other licensed HBsAg assays (as recorded in the certificates of analysis).
GS HBsAg 3.0 Static Procedure
- Earlier detection on 12 out of 19 seroconversions for HBsAg 3.0 versus competitor assay number 1
- Earlier detection on 16 out of 20 seroconversions for HBsAg 3.0 versus competitor assay number 2
GS HBsAg 3.0 Shaking Procedure
- Earlier detection on 15 out of 19 seroconversions versus competitor assay number 1
- Earlier detection on 18 out of 20 seroconversions versus competitor assay number 2